loading
GCP Training in Canada

Good Clinical Practices: Essential Training Guide 2026

Overview

Good Clinical Practices (Health Canada)ย training is essential for all professionals involved in clinical research in Canada. With the adoption of ICH E6(R3) effective April 1, 2026, staying current with updated GCP requirements is more important than ever. This guide provides an overview of essential GCP training and the programs available to help you achieve and maintain compliance with Health Canada regulations.

Why GCP Training is Essential in 2026

Good Clinical Practices (Health Canada) training is essential for several reasons:

  • Regulatory Compliance โ€“ meeting Part C, Division 5 and ICH E6(R3) requirements
  • Participant Protection โ€“ ensuring informed consent and safety monitoring
  • Data Integrity โ€“ maintaining accurate and reliable trial data
  • Inspection Readiness โ€“ preparing for Health Canada GCP inspections
  • Career Advancement โ€“ demonstrating your commitment to quality and compliance

What to Look for in GCP Training

When selectingย GCP Health Canadaย training, look for programs that offer:

  • Comprehensive content โ€“ covering Part C, Division 5 and ICH E6(R3)
  • Practical application โ€“ with case studies and real-world scenarios
  • Assessments โ€“ to verify understanding and retention
  • Certificate of completion โ€“ for professional records and regulatory inspections
  • Updates โ€“ to reflect the latest regulatory changes

Detailed Course Breakdown


Course 1: Good Clinical Practices (Health Canada)

This comprehensive training program provides clinical research professionals with the knowledge and practical skills required to conduct clinical trials in compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the ICH E6(R3) Good Clinical Practice (GCP) guideline.

Scope: The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026. It covers Health Canada regulatory requirements, sponsor and Qualified Investigator responsibilities, clinical trial application processes, informed consent, safety reporting, data governance, quality management, and inspection readiness.

Description of Modules: The curriculum covers:

  • Health Canada regulatory requirements for clinical trials (Part C, Division 5)
  • ICH E6(R3) Good Clinical Practice principles and Annex 1
  • Sponsor, Qualified Investigator (QI), and Research Ethics Board (REB) responsibilities
  • Clinical trial application (CTA) and amendment (CTA-A) processes
  • Informed consent requirements and participant protection
  • Safety reporting obligations (AEs, SAEs, SUSARs)
  • Data governance and record keeping requirements
  • Quality management and risk-based monitoring
  • Investigational product management and GMP compliance
  • Clinical trial inspections and enforcement

Target Audience:

  • Sponsors (commercial and non-commercial/academic)
  • Qualified Investigators (QIs) and Principal Investigators
  • Sub-Investigators and clinical research staff
  • Research Ethics Board (REB) members and administrators
  • Clinical Research Coordinators and study site personnel
  • Contract Research Organizations (CROs) and Service Providers
  • Data managers and biostatisticians
  • Clinical monitors and auditors
  • Regulatory affairs professionals
  • Quality assurance professionals
  • Pharmacovigilance professionals

Pricing: Competitive pricing with group discounts available.

FAQ:

  • Who needs Good Clinical Practices (Health Canada) training? Anyone involved in clinical trials of drugs in human participants in Canada, including sponsors, investigators, REB members, and CRO staff.
  • What is the deadline for updating GCP training to ICH E6(R3)? Health Canada implemented ICH E6(R3) on April 1, 2026. All clinical trial personnel should complete updated training.
  • How often should GCP training be renewed? It is recommended to complete refresher training annually to stay current with regulatory updates.
  • Is the training certificate recognized by Health Canada? Yes, the certificate of completion is recognized for regulatory compliance and audit purposes.
  • What are the key differences between Health Canada GCP and ICH E6(R3)? Health Canada has adopted ICH E6(R3) as the standard, so they are aligned.

Enroll Now: https://www.gxptrainings.com/courses/health-canada-good-clinical-practice-training/


Course 2: Good Clinical Practices (ICH E6(R3) Focused)

This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline.

Scope: The curriculum is structured to guide participants through the entire guideline, covering the 11 fundamental principles, the expanded roles and responsibilities of sponsors and investigators, rigorous data governance frameworks, and the critical requirements for essential records.

Description of Modules: The curriculum covers:

  • ICH E6(R3) overview and its significance in global clinical research
  • 11 Fundamental Principles of GCP and their application
  • Sponsor responsibilities including oversight and quality management
  • Investigator responsibilities including delegation and supervision
  • Informed consent requirements and documentation
  • Data governance and integrity frameworks
  • Essential records and Trial Master File requirements
  • Safety reporting and pharmacovigilance obligations
  • Risk-based approaches to trial management
  • Digital technologies and decentralized trial elements

Target Audience:

  • Clinical Investigators and Sub-Investigators
  • Sponsor Personnel (Medical, Regulatory, Clinical Operations)
  • Clinical Research Associates (Monitors)
  • IRB/IEC Members and Coordinators
  • Data Management and Biostatistics Professionals
  • Quality Assurance and Compliance Staff
  • Clinical Trial Coordinators and Site Staff
  • Pharmacovigilance and Safety Specialists
  • Regulatory Affairs Professionals
  • Clinical Research Organization (CRO) Personnel

Pricing: $149.00 with group discounts available.

FAQ:

  • How does ICH E6(R3) training complement Health Canada GCP training? It provides deeper understanding of the global standard that Health Canada has adopted.
  • What are the 11 fundamental principles of GCP? They cover the ethical and scientific foundation of clinical trials.
  • How does ICH E6(R3) address risk-based approaches? It emphasizes proportionate and risk-based approaches to trial management.
  • What is the significance of Annex 1 in ICH E6(R3)? Annex 1 provides specific guidance on interventional clinical trials.
  • Why is ICH E6(R3) important for Canadian researchers? Health Canada has adopted ICH E6(R3) as the standard for GCP in Canada.

Enroll Now: https://www.gxptrainings.com/courses/ich-e6r3-good-clinical-practices-gcp/


Course 3: HIPAA Clinical Data Privacy, Security & Compliance Training

This training program provides organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.

Scope: The program covers the full spectrum of privacy, security, and compliance obligations under U.S. federal law and international good practice standards.

Description of Modules: The curriculum covers 10 comprehensive sections:

  • HIPAA Overview and regulatory landscape
  • HIPAA Privacy Rule requirements and PHI protections
  • HIPAA Security Rule requirements and ePHI safeguards
  • HIPAA Breach Notification Rule requirements
  • GCP and clinical data integrity requirements
  • Security controls for information systems and cloud environments
  • Regulatory compliance frameworks including FDA, NIST, and ISO
  • Incident management and breach response
  • Risk assessment methodologies
  • Roles and responsibilities of Sponsors, CROs, Investigators, and technology vendors

Target Audience:

  • Covered Entities under HIPAA
  • Business Associates and their subcontractors
  • Clinical Research Professionals
  • Security and Compliance Professionals

Pricing: $249.00 with group discounts available.

FAQ:

  • Why is HIPAA training important for Canadian researchers? It provides understanding of data privacy requirements for cross-border clinical research.
  • What is Protected Health Information (PHI)? PHI is health information that identifies an individual.
  • What is the difference between the HIPAA Privacy Rule and Security Rule? The Privacy Rule protects the privacy of PHI, while the Security Rule establishes standards for protecting ePHI.
  • What is a breach under HIPAA? A breach is the unauthorized acquisition, access, use, or disclosure of PHI.
  • How can I ensure HIPAA compliance in clinical trials? Compliance requires appropriate policies, training, technical safeguards, and oversight of business associates.

Enroll Now: https://www.gxptrainings.com/courses/hipaa-clinical-data-privacy-security-compliance-training/


Course 4: GCP Global Auditor Certification Program

This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).

Scope: The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5, and FDA regulations with auditing practices based on ISO 19011:2026.

Description of Modules: The curriculum covers:

  • Regulatory Frameworks including ICH E6(R3), Health Canada Division 5, and FDA 21 CFR
  • Auditing Practices based on ISO 19011:2026
  • Remote auditing methods including virtual audits
  • Second-party auditing including supplier qualification

Target Audience:

  • Quality Assurance Personnel
  • Clinical Research Associates (Monitors)
  • Study Directors and Clinical Trial Managers
  • Clinical Investigators and Site Staff
  • Sponsor Personnel
  • CRO Personnel
  • IRB/IEC Members and Coordinators

Pricing: $499.00 with group discounts available.

FAQ:

  • What is the role of ISO 19011:2026 in GCP auditing? It provides the methodological framework for planning, conducting, reporting, and following up on audits.
  • What are the key elements of audit programme management? Objectives, risks, resources, procedures, implementation, monitoring, review, and improvement.
  • What is remote auditing and when is it used? Remote auditing uses virtual methods and technology to conduct audits.
  • What is second-party auditing? Second-party auditing involves auditing suppliers, vendors, and service providers.
  • What is the importance of auditor competence? Auditors must demonstrate personal behaviour, knowledge, skills, and maintain competence through ongoing evaluation.

Enroll Now: https://www.gxptrainings.com/courses/gcp-global-auditor-certification-program/


Course 5: Certified Regulatory Affairs Professional (CRAP)

This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape.

Scope: The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management.

Description of Modules: The curriculum covers:

  • Global Regulatory Framework overview
  • Investigational New Drug (IND) applications
  • New Drug Applications (NDA) for innovative pharmaceuticals
  • Abbreviated New Drug Applications (ANDA) for generics
  • Biologics License Applications (BLA) for biological products
  • Orphan Drug Designation for rare disease treatments
  • Special Programs including Accelerated Approval and Breakthrough Therapy
  • Post-approval lifecycle management
  • Regulatory agency interactions and meeting management
  • Global regulatory strategy development

Target Audience:

  • Regulatory Affairs Professionals
  • Pharmaceutical Development and Formulation Scientists
  • Quality Assurance/Quality Control Professionals
  • Clinical and Nonclinical Development Professionals

Pricing: $799.00 with group discounts available.

FAQ:

  • How does regulatory affairs training support GCP compliance? It provides the knowledge needed to navigate complex regulatory requirements.
  • What is the difference between an IND and an NDA? An IND authorizes clinical trials, while an NDA requests marketing approval.
  • What is the eCTD format and why is it important? eCTD is the standard format for regulatory submissions.
  • What is the purpose of an Orphan Drug Designation? It provides incentives for developing drugs for rare diseases.
  • What is the role of ICH in global drug development? ICH harmonizes regulatory requirements across regions.

Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/


Get Your Team Offer

For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.

Contact Us: https://www.gxptrainings.com/contact-us/

Authors

  • We provide training programs designed to help you meet quality and compliance standards. Our courses cover GMP, GLP, GCP, GEP, GDP, and Quality Assurance.

  • GCP Subject Matter Expert (SME)

    Sarah M. Richardson is a Senior Good Clinical Practices (GCP) Subject Matter Expert (SME) with 28+ years of experience supporting global clinical development programs across Phase Iโ€“IV clinical trials.